Supervised Home-Based Telerehabilitation for Idiopathic Pulmonary Fibrosis: A Pragmatic Service Evaluation in Routine Care with Detraining Follow-up

Vasileios Stavrou; Konstantinos Korakas; Glykeria Tsirimona; Eleni Karetsi; Antonios Charokopos; Zoe Daniil

doi:10.36141/svdld.2026.18236

Authors

Vasileios Stavrou Medical School, University of Cyprus, Cyprus; Unique Safe Tele Exercise Project – Institute for Digital Health and Chronic Diseases, Greece; Laboratory of Cardio-Pulmonary Testing and Pulmonary Rehabilitation, Department of Respiratory Medicine, Faculty of Medicine, University of Thessaly, Greece
Konstantinos Korakas Laboratory of Cardio-Pulmonary Testing and Pulmonary Rehabilitation, Department of Respiratory Medicine, Faculty of Medicine, University of Thessaly, Greece
Glykeria Tsirimona Unique Safe Tele Exercise Project – Institute for Digital Health and Chronic Diseases, Greece
Eleni Karetsi Laboratory of Cardio-Pulmonary Testing and Pulmonary Rehabilitation, Department of Respiratory Medicine, Faculty of Medicine, University of Thessaly, Greece.
Antonios Charokopos Medical School, University of Cyprus, Cyprus
Zoe Daniil Laboratory of Cardio-Pulmonary Testing and Pulmonary Rehabilitation, Department of Respiratory Medicine, Faculty of Medicine, University of Thessaly, Greece

Keywords:

six minute walk test, emotional well being, pulse-respiration quotient

Abstract

Abstract

Background and aim: In this pragmatic, uncontrolled service evaluation in clinically stable idiopathic pulmonary fibrosis (IPF), we assessed primary service outcomes (feasibility and safety) and prespecified exploratory within-participant changes following a four-week supervised home-based tele-exercise program via the USTEP platform and a four-week detraining period.

Methods: Thirteen participants were assessed at three prespecified time points (baseline: T0; post-intervention: T1; post-detraining: T2) using the six-minute walk test (6MWT), SF-36, HADS, and pulse–respiration quotient (PRQ). Primary service outcomes were captured as session attendance/adherence and exercise-related adverse events.

Results: Adherence was 92% (median 11/12 sessions completed) and there were no exercise-related adverse events. The 6MWT distance increased by 8.4% from T0–T1 (Bonferroni-adjusted p=0.004, d=-1.15) but declined towards baseline at T2. SF-36 physical health scores increased at T1 (+5.2%) but decreased at T2 (Bonferroni-adjusted T1–T2 p=0.004, d=1.17). For several exploratory patient-reported outcomes (fatigue, pain and HADS), Bonferroni-adjusted comparisons were non-significant, while unadjusted testing suggested small T0–T1 changes; these are reported as exploratory signals. PRQ changed over time (χ²(2)=8.60, p=0.014), with a shift at T1 and a return to baseline at T2.

Conclusions: In this small uncontrolled service evaluation, the program was feasible and safe and within-participant improvements were observed in 6MWT distance and selected patient-reported and physiological measures. These findings are exploratory and hypothesis-generating and should be confirmed in adequately powered controlled studies that include prespecified maintenance strategies.

References

1. Raghu G, Collard HR, Egan JJ, et al. An official ATS/ERS/JRS/ALAT statement: idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and management. Am J Respir Crit Care Med. 2011;183(6):788-824. doi: 10.1164/rccm.2009-040GL.

2. Sankari A, Chapman K, Ullah S. Idiopathic pulmonary fibrosis. In: StatPearls. Treasure Island (FL): StatPearls Publishing; 2025.

3. Richeldi L, Collard HR, Jones MG. Idiopathic pulmonary fibrosis. Lancet. 2017;389(10082):1941-52. doi: 10.1016/S0140-6736(17)30866-8.

4. Barratt SL, Creamer A, Hayton C, Chaudhuri N. Idiopathic pulmonary fibrosis (IPF): an overview. J Clin Med. 2018;7(8):201. doi: 10.3390/jcm7080201.

5. King TE Jr, Bradford WZ, Castro-Bernardini S, et al. A phase 3 trial of pirfenidone in patients with idiopathic pulmonary fibrosis. N Engl J Med. 2014;370(22):2083-92. doi: 10.1056/NEJMoa1402582.

6. Leask A, Abraham DJ. TGF-beta signaling and the fibrotic response. FASEB J. 2004;18(7):816-27. doi: 10.1096/fj.03-1273rev.

7. Neely ML, Hellkamp AS, Bender S, et al. Lung function trajectories in patients with idiopathic pulmonary fibrosis. Respir Res. 2023;24(1):209. doi: 10.1186/s12931-023-02503-5.

8. Spruit MA, Singh SJ, Garvey C, et al. An official American Thoracic Society/European Respiratory Society statement: key concepts and advances in pulmonary rehabilitation. Am J Respir Crit Care Med. 2013;188(8):e13-64. doi: 10.1164/rccm.201309-1634ST.

9. Cox IA, Borchers Arriagada N, de Graaff B, et al. Health-related quality of life of patients with idiopathic pulmonary fibrosis: a systematic review and meta-analysis. Eur Respir Rev. 2020;29(158):200154. doi: 10.1183/16000617.0154-2020.

10. Gloeckl R, Teschler S, Jarosch I, Christle JW, Hitzl W, Kenn K. Comparison of two- and six-minute walk tests in detecting oxygen desaturation in patients with severe chronic obstructive pulmonary disease-a randomized crossover trial. Chron Respir Dis. 2016;13(3):256-63. doi: 10.1177/1479972316636991.

11. Vainshelboim B. Exercise training in idiopathic pulmonary fibrosis: is it of benefit? Breathe (Sheff). 2016;12(2):130-8. doi: 10.1183/20734735.006916.

12. Edwards GD, Polgar O, Patel S, et al. Mood disorder in idiopathic pulmonary fibrosis: response to pulmonary rehabilitation. ERJ Open Res. 2023;9(3):00585-2022. doi: 10.1183/23120541.00585-2022.

13. Wallaert B, Monge E, Le Rouzic O, Wémeau-Stervinou L, Salleron J, Grosbois JM. Physical activity in daily life of patients with fibrotic idiopathic interstitial pneumonia. Chest. 2013;144(5):1652-8. doi: 10.1378/chest.13-0806.

14. Flaherty KR, Mumford JA, Murray S, et al. Prognostic implications of physiologic and radiographic changes in idiopathic interstitial pneumonia. Am J Respir Crit Care Med. 2003;168(5):543-8. doi: 10.1164/rccm.200209-1112OC.

15. Stavrou VT, Vavougios GD, Astara K, et al. The impact of different exercise modes in fitness and cognitive indicators: hybrid versus tele-exercise in patients with long post-COVID-19 syndrome. Brain Sci. 2024;14(7):693. doi: 10.3390/brainsci14070693.

16. Zamparelli SS, Lombardi C, Candia C, et al. The beneficial impact of pulmonary rehabilitation in idiopathic pulmonary fibrosis: a review of the current literature. J Clin Med. 2024;13(7):2026. doi: 10.3390/jcm13072026.

17. Rochester CL, Alison JA, Carlin B, et al. Pulmonary rehabilitation for adults with chronic respiratory disease: an official American Thoracic Society clinical practice guideline. Am J Respir Crit Care Med. 2023;208(4):e7-e26. doi: 10.1164/rccm.202306-1066ST.

18. Razvi Y, Ladie DE. Cardiopulmonary exercise testing. In: StatPearls. Treasure Island (FL): StatPearls Publishing; 2025.

19. Stavrou VT, Astara K, Ioannidis P, Vavougios GD, Daniil Z, Gourgoulianis KI. Tele-exercise in non-hospitalized versus hospitalized post-COVID-19 patients. Sports (Basel). 2022;10(11):179. doi: 10.3390/sports10110179

20. Resneck JS Jr. Revisions to the Declaration of Helsinki on its 60th anniversary: a modernized set of ethical principles to promote and ensure respect for participants in a rapidly innovating medical research ecosystem. JAMA. 2025;333:15-17. doi: 10.1001/jama.2024.21902.

21. ATS Committee on Proficiency Standards for Clinical Pulmonary Function Laboratories. ATS statement: guidelines for the six-minute walk test. Am J Respir Crit Care Med. 2002;166:111-17. doi: 10.1164/ajrccm.166.1.at1102.

22. Stavrou VT, Vavougios GD, Astara K, Siachpazidou DI, Papayianni E, Gourgoulianis KI. The 6-minute walk test and anthropometric characteristics as assessment tools in patients with obstructive sleep apnea syndrome. A preliminary report during the pandemic. J Pers Med. 2021;11:563. doi: 10.3390/jpm11060563.

23. Stavrou VT, Vavougyios GD, Tsirimona G, et al. The effects of 4-week respiratory muscle training on cardiopulmonary parameters and cognitive function in male patients with OSA. Applied Sciences. 2025;15(5):2532. doi: 10.3390/app15052532.

24. DeMers D, Wachs D. Physiology, mean arterial pressure. In: StatPearls. Treasure Island (FL): StatPearls Publishing; 2024.

25. Stavrou VT, Karetsi E, Gourgoulianis KI. The effect of growth and body surface area on cardiopulmonary exercise testing: a cohort study in preadolescent female swimmers. Children. 2023;10:1608. doi: 10.3390/children10101608.

26. Scholkmann F, Wolf U. The pulse-respiration quotient: a powerful but untapped parameter for modern studies about human physiology and pathophysiology. Front Physiol. 2019;10:371. doi: 10.3389/fphys.2019.00371.

27. Enright PL, Sherrill DL. Reference equations for the six-minute walk in healthy adults. Am J Respir Crit Care Med. 1998;158(5 Pt 1):1384-7. doi: 10.1164/rccm.v201erratum1.

28. Stavrou VT, Vavougios GD, Bardaka F, Karetsi E, Daniil Z, Gourgoulianis KI. The effect of exercise training on the quality of sleep in national-level adolescent finswimmers. Sports Med Open. 2019;5:34. doi: 10.1186/s40798-019-0207-y.

29. Pappa E, Kontodimopoulos N, Niakas D. Validating and norming of the Greek SF-36 Health Survey. Qual Life Res. 2005;14(5):1433-8. doi: 10.1007/s11136-004-6014-y.

30. Michopoulos I, Douzenis A, Kalkavoura C, et al. Hospital Anxiety and Depression Scale (HADS): validation in a Greek general hospital sample. Ann Gen Psychiatry. 2008;7:4. doi: 10.1186/1744-859X-7-4.

31. Plantier L, Cazes A, Dinh-Xuan AT, Bancal C, Marchand-Adam S, Crestani B. Physiology of the lung in idiopathic pulmonary fibrosis. Eur Respir Rev. 2018;27(147):170062. doi: 10.1183/16000617.0062-2017.

32. Bueno M, Calyeca J, Rojas M, Mora AL. Mitochondria dysfunction and metabolic reprogramming as drivers of idiopathic pulmonary fibrosis. Redox Biol. 2020;33:101509. doi: 10.1016/j.redox.2020.101509.

33. Kadura S, Purkayastha S, Benditt J, et al. Yoga effect on quality-of-life study among patients with idiopathic pulmonary fibrosis (YES-IPF) [Preprint]. medRxiv. 2025. doi: 10.1101/2025.05.20.25327762.

34. Maltais F, Simard AA, Simard C, Jobin J, Desgagnés P, LeBlanc P. Oxidative capacity of the skeletal muscle and lactic acid kinetics during exercise in normal subjects and in patients with COPD. Am J Respir Crit Care Med. 1996;153(1):288-93. doi: 10.1164/ajrccm.153.1.8542131.

35. Herigstad M, Hayen A, Evans E, et al. Dyspnea-related cues engage the prefrontal cortex: evidence from functional brain imaging in COPD. Chest. 2015;148(4):953-61. oi: 10.1378/chest.15-0416.

36. Stendardi L, Grazzini M, Gigliotti F, Lotti P, Scano G. Dyspnea and leg effort during exercise. Respir Med. 2005;99(8):933-42. doi: 10.1016/j.rmed.2005.02.005.

37. Kinnula VL, Myllärniemi M. Oxidant-antioxidant imbalance as a potential contributor to the progression of human pulmonary fibrosis. Antioxid Redox Signal. 2008;10(4):727-38. doi: 10.1089/ars.2007.1942.

38. Amann M, Romer LM, Subudhi AW, Pegelow DF, Dempsey JA. Severity of arterial hypoxaemia affects the relative contributions of peripheral muscle fatigue to exercise performance in healthy humans. J Physiol. 2007;581(Pt 1):389-403. doi: 10.1113/jphysiol.2007.129700.

39. Magnon V, Dutheil F, Vallet GT. Benefits from one session of deep and slow breathing on vagal tone and anxiety in young and older adults. Sci Rep. 2021;11:19267. doi: 10.1038/s41598-021-98736-9.

40. McCambridge J, Witton J, Elbourne DR. Systematic review of the Hawthorne effect: new concepts are needed to study research participation effects. J Clin Epidemiol. 2014;67(3):267-77. doi: 10.1016/j.jclinepi.2013.08.015.

41. Matteucci A, Bonanni M, Centioni M, et al. Home management of heart failure and arrhythmias in patients with cardiac devices during pandemic. J Clin Med. 2021;10(8):1618. doi: 10.3390/jcm10081618.

42. Marillier M, Bernard AC, Verges S, Moran-Mendoza O, Neder JA. Quantifying leg muscle deoxygenation during incremental cycling in hypoxemic patients with fibrotic interstitial lung disease. Clin Physiol Funct Imaging. 2023;43(3):192-200. doi: 10.1111/cpf.12809.